Search - tctmd.com

Displaying 41 - 55 of 55

Sort: Relevancy | Date

News Daily News

Vascular Solutions 召回双通双通路导管

Michael O'Riordan

October 06, 2016

News Daily News

Vascular Solutions Retira los Catéteres Gemelos de Doble Vía

Michael O'Riordan

October 06, 2016

News Daily News

Vascular Solutions Recalls Twin-Pass Dual-Access Catheters

Michael O'Riordan

October 06, 2016

News Daily News

Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter

Michael O'Riordan

August 18, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

FDA: Global Recall for Roadrunner UniGlide Wire Guides After Coating Contaminated

Michael O'Riordan

August 17, 2016

News Daily News

Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes

Michael O'Riordan

August 12, 2016

News Daily News

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Michael O'Riordan

August 09, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Daily News

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Michael O'Riordan

June 30, 2016

News Daily News

FDA 顾问小组小范围建议使用糖尿病药物 empagliflozin 来改善 CVD 死亡率

Michael O'Riordan

June 30, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

News Daily News

止泻药洛哌丁胺的滥用与严重心脏事件包括死亡相关

Michael O'Riordan

June 08, 2016

News Daily News

Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide

Michael O'Riordan

June 08, 2016

News Daily News

Los Episodios Cardíacos Serios, incluida la Muerte se asocian a un Abuso del Fármaco Antidiarréico Lorepamida

Michael O'Riordan

June 08, 2016

Advertisement

Vascular Solutions 召回双通双通路导管

Vascular Solutions Retira los Catéteres Gemelos de Doble Vía

Vascular Solutions Recalls Twin-Pass Dual-Access Catheters

Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

FDA: Global Recall for Roadrunner UniGlide Wire Guides After Coating Contaminated

Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

FDA 顾问小组小范围建议使用糖尿病药物 empagliflozin 来改善 CVD 死亡率

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

止泻药洛哌丁胺的滥用与严重心脏事件包括死亡相关

Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide

Los Episodios Cardíacos Serios, incluida la Muerte se asocian a un Abuso del Fármaco Antidiarréico Lorepamida

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content